5Deo R,Varosy PD. Invited commentary-Global arrhythmia burden.the public health implications of the rise in atrial fibrillation comment on "The increasing burden of atrial fibrillation compared with heart failure and myocardial in-farction" [J]. Arch Intern Med, 2012,172 : 741-742.
6Wong CX,Brooks AG,Leong DP,et al. The increasing bur- den of atrial fibrillation compared with heart failure and myocardial infarction:a 15-year study of all hospitalizations in Australia [J]. Arch Intern Med,2012,172:739-741.
7Talajic M, Khairy P, Levesque S, et al. Maintenance of sinus rhythm and survival in patients with heart failure and atri- al fibrillation [J]. J Am Coll Cardiol,2010,55 (17):1796- 1802.
8Elayi CS,Whitebeck MG,Charnigo R,et al. Is there an as- sociation between external cardioversions and long-term mortality and morbidity Insights from the atrial fibrillation follow-up investigation of Rhythm Management study [J]. Circ Arrhythm Electrophysio1,2011,4(4) :465-469.
9Siu CW,Lau CP,Lee WL,et al. Intravenous diltiazem is su- perior to intravenous amiod arone or digoxin forachieving ventricular rate control in patients with acute uncomplicat- ed atrialfibrillation [J]. Crit Care Med,2009,37(7):2174- 2179.
10Gonzalez ER, Omato JP,Lawson CL. Clinical decision anal- ysis modeling:short-term control of ventricular responser- ate in atrial fibrillation or atrial flutter-digoxin versus dil- tiazem [J]. Pharmacotherapy, 1994,14 (4) : 446-451.
